Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -54.01% is 18% above its 5-year average of -65.68%, near the high end of its 5-year range (-195.04%–0.00%).
33.32% above its 12-month average of -81.00%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -21.49%.
RETURN ON ASSETS (ROA)
-54.01%
RETURN ON ASSETS (ROA) AVG TTM
-81.00%
RETURN ON ASSETS (ROA) AVG 3Y
-93.15%
RETURN ON ASSETS (ROA) AVG 5Y
-65.68%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.32%
CURRENT VS 3Y AVG
+42.02%
CURRENT VS 5Y AVG
+17.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-67.52%
vs the sector median at left
Spectral AI, Inc.
Market Cap
$52.99M
Return on Assets (ROA)
-54.01%
TTM Avg
-81.00%
3Y Avg
-93.15%
5Y Avg
-65.68%
Market Cap
$53.12M
Return on Assets (ROA)
-32404.78%
TTM Avg
-23.59%
3Y Avg
-11.80%
5Y Avg
-9.44%
Market Cap
$52.60M
Return on Assets (ROA)
-15.99%
TTM Avg
-6.85%
3Y Avg
0.40%
5Y Avg
2.07%
Market Cap
$53.71M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
Market Cap
$51.98M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
Market Cap
$51.43M
Return on Assets (ROA)
-34.52%
TTM Avg
-27.74%
3Y Avg
-32.72%
5Y Avg
-28.49%
Market Cap
$54.46M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$50.99M
Return on Assets (ROA)
-97.71%
TTM Avg
-228.91%
3Y Avg
-360.64%
5Y Avg
-295.62%
Market Cap
$50.66M
Return on Assets (ROA)
-53.31%
TTM Avg
-34.34%
3Y Avg
-114.79%
5Y Avg
-190.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.99M | -54.01% | -81.00% | -93.15% | -65.68% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.12M | -32404.78% | -23.59% | -11.80% | -9.44% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -15.99% | -6.85% | 0.40% | 2.07% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $53.71M | -49.54% | -66.28% | -54.88% | -41.21% |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | -127.67% | -99.17% | -76.90% | -71.83% |
| ImageneBio Inc (IMA)vs › | $51.43M | -34.52% | -27.74% | -32.72% | -28.49% |
| Aldeyra The (ALDX)vs › | $54.46M | -48.49% | -50.18% | -39.97% | -38.29% |
| Envoy Medical, Inc. (COCH)vs › | $50.99M | -97.71% | -228.91% | -360.64% | -295.62% |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | -53.31% | -34.34% | -114.79% | -190.75% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A | -109.69% | -346.56% | -277.44% |
ROA
-54.0%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -35.37% |
| 2024-12-31 | -126.62% |
| 2023-12-31 | -195.04% |
| 2022-12-31 | -15.56% |
| 2021-12-31 | -21.51% |
| 2020-12-31 | 0.00% |
